Showing results (171-180 of 332) with videos related to
Sort By:
Pageof 34
Digital Discovery|August 21, 2025
Identifying 14-3-3 interactome binding sites with deep learningLaura van Weesep, Rıza Özçelik, Marloes Pennings, et al.Journal of Medicinal Chemistry|May 31, 2023
De Novo Design of Nurr1 Agonists via Fragment-Augmented Generative Deep Learning in Low-Data RegimeMarco Ballarotto, Sabine Willems, Tanja Stiller, et al.Chembiochem : a European Journal of Chemical Biology|May 15, 2002
A virtual screening method for prediction of the HERG potassium channel liability of compound librariesOlivier Roche, Gerhard Trube, Jochen Zuegge, et al.Molecular Biosystems|December 25, 2010
Long signal peptides of RGMa and DCBLD2 are dissectible into subdomains according to the NtraC modelEduard Resch, Jan A Hiss, Alexander Schreiner, et al.Nature Reviews. Drug Discovery|December 17, 2011
Designing antimicrobial peptides: form follows functionChristopher D Fjell, Jan A Hiss, Robert E W Hancock, et al.European Journal of Pharmacology|February 26, 2009
MK-886, an inhibitor of the 5-lipoxygenase-activating protein, inhibits cyclooxygenase-1 activity and suppresses platelet aggregationAndreas Koeberle, Ulf Siemoneit, Hinnak Northoff, et al.Ebiomedicine|July 3, 2015
Unraveling the Activation Mechanism of Taspase1 which Controls the Oncogenic AF4-MLL Fusion ProteinSamaneh Sabiani, Tim Geppert, Christian Engelbrecht, et al.Trends in Biotechnology|November 14, 2008
Voyages to the (un)known: adaptive design of bioactive compoundsGisbert Schneider, Markus Hartenfeller, Michael Reutlinger, et al.Plos One|February 7, 2008
The Plasmodium export element revisitedJan Alexander Hiss, Jude Marek Przyborski, Florian Schwarte, et al.Journal of Medicinal Chemistry|October 28, 2005
Extraction and visualization of potential pharmacophore points using support vector machines: application to ligand-based virtual screening for COX-2 inhibitorsLutz Franke, Evgeny Byvatov, Oliver Werz, et al.Pageof 34